New FDA-approved medical treatments can be transformative for patients and families, often providing them with more years to live and an enhanced quality of life. 1 Delivering timely, high-quality ...

Homozygous deficiency of alpha 1-atitrypsin is known to predispose to pulmonary emphysema. Measurement of the trypsin inhibitory capacity (TIC) of serum specimens from 28 relatives of a homozygous ...

COPD treatments aim to improve patients' quality of life, with options including medication, rehabilitation, and invasive procedures. Emphysema significantly impacts patients' daily activities due to ...

People with Chronic Obstructive Pulmonary Disease (COPD) need more support when understanding and acting on new chest symptoms, a study in the journal Psycho-Oncology reports. During this unique study ...

A procedure known as lung-volume reduction surgery (LVRS) appears to improve overall health and quality of life for individuals with end-stage emphysema, and these effects last as long as five years ...

Please provide your email address to receive an email when new articles are posted on . The prevalence and incidence of secondary spontaneous pneumothorax among patients with chronic obstructive ...

Surgically removing part of the lungs improves the day-to-day functioning and quality of life of some people suffering from the lung disease emphysema and may even prolong their lives, according to ...

Patients with respiratory conditions, such as asthma and COPD, are being encouraged to use apps to manage their symptoms.

Chronic obstructive pulmonary disease (COPD) remains highly prevalent among veterans, but the contribution of alpha-1 antitrypsin deficiency (AAT deficiency or AATD) to this patient population remains ...